NASDAQ:PODD
Insulet Corporation Stock News
$185.38
+4.82 (+2.67%)
At Close: May 16, 2024
Insulet Q1 Earnings Beats Street View, Says Omnipod 5 Rollout Is 'Progressing Very Well'
09:57am, Friday, 06'th May 2022
Insulet Corporation (NASDAQ: PODD) posted Q1 profits of $27.8 million, or an EPS of $0.40, beating the consensus of $0.23. Q1 sales increased 17.1% Y/Y, or 19.3% in constant currency, to $295.4 mill
Insulet (PODD) Tops Q1 Earnings and Revenue Estimates
09:15pm, Thursday, 05'th May 2022 Zacks Investment Research
Insulet (PODD) delivered earnings and revenue surprises of 73.91% and 3.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Insulet (PODD) Tops Q1 Earnings and Revenue Estimates
06:49pm, Thursday, 05'th May 2022
Insulet (PODD) delivered earnings and revenue surprises of 73.91% and 3.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Medical Product Stocks' Earnings May 5 Roster: MCK, CAH & PODD
05:49pm, Wednesday, 04'th May 2022 Zacks Investment Research
The Medical Product companies' quarterly results are likely to reflect base business recovery. Let's see how MCK, CAH and PODD are poised ahead of their earnings releases.
Medical Product Stocks' Earnings May 5 Roster: MCK, CAH & PODD
01:32pm, Wednesday, 04'th May 2022
The Medical Product companies' quarterly results are likely to reflect base business recovery. Let's see how MCK, CAH and PODD are poised ahead of their earnings releases.
Refresh Your Portfolio by Dumping These 5 Toxic Stocks
12:31pm, Monday, 02'nd May 2022 Zacks Investment Research
Get rid of toxic stocks like GoodRx (GDRX), Insulet (PODD), Vonage (VG), AppLovin (APP) and Embraer (ERJ) to avoid portfolio bleeding.
Refresh Your Portfolio by Dumping These 5 Toxic Stocks
09:47am, Monday, 02'nd May 2022
Get rid of toxic stocks like GoodRx (GDRX), Insulet (PODD), Vonage (VG), AppLovin (APP) and Embraer (ERJ) to avoid portfolio bleeding.
Here's Why You Should Hold on to Insulet (PODD) Stock For Now
01:33pm, Monday, 18'th Apr 2022 Zacks Investment Research
Investors are optimistic about Insulet (PODD) on robust uptake of the Omnipod system and bullish guidance.
Here's Why You Should Hold on to Insulet (PODD) Stock For Now
11:17am, Monday, 18'th Apr 2022
Investors are optimistic about Insulet (PODD) on robust uptake of the Omnipod system and bullish guidance.
Insulet to Announce First Quarter 2022 Financial Results on May 5, 2022
06:00am, Thursday, 07'th Apr 2022
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
What Makes Insulet Stock A Good Bet?
06:30am, Friday, 01'st Apr 2022
We think that Insulet stock, a company best known for selling the Omnipod continuous insulin delivery system that caters to people with diabetes, currently is a better pick compared to ConMed (NASDAQ:
Insulet (PODD) Down 1.5% Since Last Earnings Report: Can It Rebound?
03:30pm, Friday, 25'th Mar 2022 Zacks Investment Research
Insulet (PODD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Insulet (PODD) Down 1.5% Since Last Earnings Report: Can It Rebound?
01:32pm, Friday, 25'th Mar 2022
Insulet (PODD) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Hold on to Insulet (PODD) Stock For Now
04:23pm, Thursday, 17'th Mar 2022 Zacks Investment Research
Investors are optimistic about Insulet's (PODD) robust uptake of the Omnipod system both in the U.S. and international markets.
Here's Why You Should Hold on to Insulet (PODD) Stock For Now
01:32pm, Thursday, 17'th Mar 2022
Investors are optimistic about Insulet's (PODD) robust uptake of the Omnipod system both in the U.S. and international markets.
